Two groups of chronic stable schizophrenics matched on several parameters but differing only with respect to presence or absence of tardive dyskinesia (TD) were compared for cognitive function using the Bexley Maudsley Automated Psychological Screen and the Category Sorting Test. The results showed
The life expectancy of schizophrenic patients with tardive dyskinesia
β Scribed by Toshiya Inada; Mika Koshiishi; Kimio Ohnishi; Gohei Yagi
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 544 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
β¦ Synopsis
Relationships between tardive dyskinesia (TD) and the life expectancy of schizophrenic patients who suffer it were examined in two studies over a 50-month period. In a prospective study, the mortality rate was found to be higher in patients with T D than in those without. This suggests either that T D is a factor tending to precipitate death, or else that it is an indication that the final period of life has been reached. The failure in the prospective study to detect medical factors which would discriminate between those T D patients who died and those who remained alive, as well as the finding of a significantly older age at death of patients with T D in the retrospective study may both support this idea. No significant differences were observed in the retrospective study in the prevalence of TD between 35 pairs of age-matched deceased and living patients. The effects of T D on life expectancy are subtle; the present results are consistent with the possibilities both that T D reduces life expectancy and that it appears at the end-stage of life.
π SIMILAR VOLUMES
## Background: Chronically hospitalized geriatric inpatients with schizophrenia are at particular risk for both tardive dyskinesia (td) and cognitive impairment but have been insufficiently studied in this regard. similarly, the relationship between td and cognitive impairment has not be adequately
Twenty-five of 76 patients suffering from chronic schizophrenia, treated in a rehabilitation centre, were found to have tardive dyskinesia (TD) according to the Tardive Dyskinesia Research Diagnostic Criteria (Schooler and Kane, 1982). Patients suffering from T D achieved significantly higher total
Glutamate decarboxylase (GAD) activity was measured in the nuclei of the basal ganglia in patients with neuroleptic-induced tardive dyskinesia (TD) and controls matched for age and premortem state. In five T D patients, who all had a sudden death, a signifcant decrease in GAD activity was found in t